ទំព័រដើម › មហារីកទ្រូង › នូវកាឡូណាខាងជើង › Durham
ការសាកល្បងគ្លីនិកសម្រាប់ មហារីកទ្រូង នៅក្នុង Durham, NC
ការសិក្សាចំនួន 64 សម្រាប់ មហារីកទ្រូង កំពុងរកអ្នកចូលរួមនៅតាមទីតាំងក្នុង និងជុំវិញ Durham (ក្នុងចម្ងាយប្រហែល 30 ម៉ាយ)។ បើកការសិក្សាមួយដើម្បីមើលថាតើនរណាអាចចូលរួម និងរបៀបទំនាក់ទំនងទៅកាន់ក្រុមការងារសិក្សា។
អត្ថបទសិក្សាផ្លូវការ (អង់គ្លេស)
កំពុងរកអ្នកចូលរួមសម្រាប់ការសិក្សាមួយនៅទីនេះ? លេចធ្លោនៅផ្នែកខាងលើនៃទំព័រនេះ — $99 សម្រាប់ 30 ថ្ងៃ →
The Vanguard Study: Testing a New Way to Screen for Cancer
កំពុងជ្រើសរើសស្វាគមន៍អ្នកស្ម័គ្រចិត្តដែលមានសុខភាពល្អ
- Durham VA Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · ឆ្ងាយ 10 ម៉ាយ
A Study of PHST001 in Advanced Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1
- Duke Cancer Institute, Durham
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- Duke University, Durham
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
កំពុងជ្រើសរើសដំណាក់កាល 3
- Duke Cancer Network, Durham
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
កំពុងជ្រើសរើសការសិក្សាសង្កេតស្វាគមន៍អ្នកស្ម័គ្រចិត្តដែលមានសុខភាពល្អ
- Durham VA Medical Center, Durham
Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer
កំពុងជ្រើសរើសដំណាក់កាល 2ស្វាគមន៍អ្នកស្ម័គ្រចិត្តដែលមានសុខភាពល្អ
- University of North Carolina, Chapel Hill · ឆ្ងាយ 10 ម៉ាយ
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
កំពុងជ្រើសរើសដំណាក់កាល 2
- UNC Hospitals, University of North Carolina at Chapel Hill, Chapel Hill · ឆ្ងាយ 10 ម៉ាយ
Radiation Therapy and Thymus Function in Young Women With Breast Cancer
កំពុងជ្រើសរើសការសិក្សាសង្កេត
- Duke Cancer Center, Durham
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1
- Duke Cancer Center, Durham
Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians
កំពុងជ្រើសរើសការសិក្សាសង្កេតស្វាគមន៍អ្នកស្ម័គ្រចិត្តដែលមានសុខភាពល្អ
- University of North Carolina, Chapel Hill · ឆ្ងាយ 10 ម៉ាយ
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
កំពុងជ្រើសរើសដំណាក់កាល 2
- Duke Cancer Institute, Durham
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
កំពុងជ្រើសរើសដំណាក់កាល 3
- Clinical Trial Site, Durham
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1
- Duke University Medical Center, Durham
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
កំពុងជ្រើសរើសដំណាក់កាល 3
- University of North Carolina Medical Center, Chapel Hill · ឆ្ងាយ 10 ម៉ាយ
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
កំពុងជ្រើសរើសដំណាក់កាល 2
- University of North Carolina Medical Center, Chapel Hill · ឆ្ងាយ 10 ម៉ាយ
Identifying Patterns in the Breath of Individuals With Breast Cancer
កំពុងជ្រើសរើសការសិក្សាសង្កេតស្វាគមន៍អ្នកស្ម័គ្រចិត្តដែលមានសុខភាពល្អ
- Duke University Medical Cente, Durham
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
កំពុងជ្រើសរើសដំណាក់កាល 2
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · ឆ្ងាយ 10 ម៉ាយ
Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease
កំពុងជ្រើសរើសដំណាក់កាល 2
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill · ឆ្ងាយ 10 ម៉ាយ
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
កំពុងជ្រើសរើសដំណាក់កាល 3
- Duke Cancer Institute, Durham
Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer Study
កំពុងជ្រើសរើសការសិក្សាសង្កេត
- University of North Carolina at Chapel Hill, Chapel Hill · ឆ្ងាយ 10 ម៉ាយ
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- Duke Cancer Institute, Durham
A Phase 1/1b Study of IAM1363 in HER2 Cancers
កំពុងជ្រើសរើសដំណាក់កាល 1
- Duke Cancer Institute, Durham
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- Duke Cancer Institute, Durham
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
កំពុងជ្រើសរើសដំណាក់កាល 3
- Duke Cancer Institute, Durham
Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers
កំពុងជ្រើសរើសដំណាក់កាល 2
- Duke University, Durham
Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST)
កំពុងជ្រើសរើសដំណាក់កាល 2
- University of North Carolina, Chapel Hill · ឆ្ងាយ 10 ម៉ាយ
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
កំពុងជ្រើសរើសដំណាក់កាល 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · ឆ្ងាយ 10 ម៉ាយ
- University of North Carolina-Hillsborough Campus, Hillsborough · ឆ្ងាយ 13 ម៉ាយ
Molecular Residual Disease Assessment in a Representative Diverse Population of Patients With Early-stage Breast Cancer
កំពុងជ្រើសរើសស្វាគមន៍អ្នកស្ម័គ្រចិត្តដែលមានសុខភាពល្អ
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · ឆ្ងាយ 10 ម៉ាយ
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
កំពុងជ្រើសរើសដំណាក់កាល 2
- University of North Carolina, Chapel Hill · ឆ្ងាយ 10 ម៉ាយ
Optimizing Surgical Decisions in Young Adults With Breast Cancer
កំពុងជ្រើសរើស
- Duke Cancer Institute, Durham
A Novel Approach Utilizing Organ Specific Age Proteomics
កំពុងជ្រើសរើសការសិក្សាសង្កេត
- University of North Carolina, Chapel Hill · ឆ្ងាយ 10 ម៉ាយ
Weight Management After Cancer for Survivors in Rural Communities
កំពុងជ្រើសរើស
- Duke University Medical Center, Durham
Behavioral Pain Intervention for Older Cancer Patients
កំពុងជ្រើសរើស
- Duke Cancer Network, Durham
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
កំពុងជ្រើសរើសដំណាក់កាល 2/3
- Duke Cancer Institute, Durham
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
កំពុងជ្រើសរើស
- Duke University/Duke Cancer Center, Durham
DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs
កំពុងជ្រើសរើសដំណាក់កាល 2
- Duke University Medical Center, Durham
Planning Grant for TOPS for Breast Cancer Survivors
កំពុងជ្រើសរើស
- Duke University, Durham
Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells
កំពុងជ្រើសរើសដំណាក់កាល 1
- University of North Carolina, Chapel Hill · ឆ្ងាយ 10 ម៉ាយ
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
កំពុងជ្រើសរើស
- Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill · ឆ្ងាយ 10 ម៉ាយ
A Study of a Decision Tool for People Considering Breast Reconstruction Surgery
កំពុងជ្រើសរើស
- Duke Cancer Institute (Data collection only), Durham
- Duke Cancer Institute (Data collection only), Durham
Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior
កំពុងជ្រើសរើសការសិក្សាសង្កេត
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · ឆ្ងាយ 10 ម៉ាយ
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
កំពុងជ្រើសរើសដំណាក់កាល 3
- Duke University Medical Center, Durham
CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer
កំពុងជ្រើសរើសដំណាក់កាល 1
- University of North Carolina, Chapel Hill · ឆ្ងាយ 10 ម៉ាយ
Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging
កំពុងជ្រើសរើសដំណាក់កាល 2ស្វាគមន៍អ្នកស្ម័គ្រចិត្តដែលមានសុខភាពល្អ
- The University of North Carolina, Chapel Hill · ឆ្ងាយ 10 ម៉ាយ
VisR Ultrasound for Noninvasively Interrogating Stromal Collagen Organization in Women as a Breast Cancer Biomarker: Evaluation of Anisotropy in Cancer Patients
កំពុងជ្រើសរើសការសិក្សាសង្កេត
- University of North Carolina at Chapel Hill, Chapel Hill · ឆ្ងាយ 10 ម៉ាយ
Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy
កំពុងជ្រើសរើសដំណាក់កាល 2
- University of North Carolina, Chapel Hill · ឆ្ងាយ 10 ម៉ាយ
Promoting Resilience in Women With Breast Cancer (PRISM -MBC)
កំពុងជ្រើសរើស
- University of North Carolina, Chapel Hill · ឆ្ងាយ 10 ម៉ាយ
Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer
កំពុងជ្រើសរើសដំណាក់កាល 2
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill · ឆ្ងាយ 10 ម៉ាយ
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
កំពុងជ្រើសរើសដំណាក់កាល 2
- The University of North Carolina at Chapel Hill, Chapel Hill · ឆ្ងាយ 10 ម៉ាយ
Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast Cancer
កំពុងជ្រើសរើសដំណាក់កាល 2
- University of North Carolina, Chapel Hill · ឆ្ងាយ 10 ម៉ាយ
PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease
កំពុងជ្រើសរើសដំណាក់កាល 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · ឆ្ងាយ 10 ម៉ាយ
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
កំពុងជ្រើសរើស
- Duke University, Durham
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- Duke Cancer Center/ DUMC, Durham
PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients
កំពុងជ្រើសរើសការសិក្សាសង្កេត
- UNC, Lineberger Comprehensive Cancer Center, Chapel Hill · ឆ្ងាយ 10 ម៉ាយ
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
កំពុងជ្រើសរើសដំណាក់កាល 2
- University of North Carolina, Chapel Hill · ឆ្ងាយ 10 ម៉ាយ
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
កំពុងជ្រើសរើសដំណាក់កាល 1
- Duke Cancer Institute, Durham
Nutrition Awareness Among Women With Non-Metastatic Breast Cancer
កំពុងជ្រើសរើស
- UNC Cancer Hospital, Chapel Hill · ឆ្ងាយ 10 ម៉ាយ
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
កំពុងជ្រើសរើស
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · ឆ្ងាយ 10 ម៉ាយ
Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
កំពុងជ្រើសរើស
- Duke Cancer Institute, Durham
Feasibility of Symptom Management for Patients With Metastatic Breast Cancer to Increase Exercise
កំពុងជ្រើសរើស
- Lineberger Comphrehensive Cancer Center at University of North Carolina at Chapel Hill, Chapel Hill · ឆ្ងាយ 10 ម៉ាយ
BREAST Choice Decision Tool R21 - AIM2
កំពុងជ្រើសរើសស្វាគមន៍អ្នកស្ម័គ្រចិត្តដែលមានសុខភាពល្អ
- The University of North Carolina, Chapel Hill · ឆ្ងាយ 10 ម៉ាយ
Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer
កំពុងជ្រើសរើស
- Duke University, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
កំពុងជ្រើសរើសការសិក្សាសង្កេត
- Massive Bio SYNERGY-AI site, Chapel Hill · ឆ្ងាយ 10 ម៉ាយ
UNC Pleural Fluid Registry
កំពុងជ្រើសរើសការសិក្សាសង្កេត
- UNC Lingeberger Comprehensive Cancer Center, Chapel Hill · ឆ្ងាយ 10 ម៉ាយ
ការសាកល្បងសម្រាប់ មហារីកទ្រូង នៅក្នុងទីក្រុងផ្សេងទៀត
- New York City, NYការសិក្សា 136
- Houston, TXការសិក្សា 126
- Boston, MAការសិក្សា 112
- Nashville, TNការសិក្សា 81
- Los Angeles, CAការសិក្សា 73
- Edison, NJការសិក្សា 68
- St. Louis, MOការសិក្សា 64
- Queens, NYការសិក្សា 64
- Chicago, ILការសិក្សា 59
- Philadelphia, PAការសិក្សា 56
- Dallas, TXការសិក្សា 55
- Arlington, VAការសិក្សា 47
ការសិក្សាផ្សេងទៀតនៅក្នុង Durham
- មហារីក (គ្រប់ប្រភេទ)ការសិក្សា 58
- Non-Small Cell Lung Cancerការសិក្សា 39
- ជំងឺ Multiple Myelomaការសិក្សា 37
- ជំងឺលីកូសេមីមីអេឡូអ៊ីដបន្ទាន់ការសិក្សា 33
- មហារីកដែលរីករាលដាលការសិក្សា 33
- មហារីកតូចការសិក្សា 32
- មហារីកសួតការសិក្សា 32
- មហារីកពោះវៀនធំ និងទ្វារមាសការសិក្សា 28
- មហារីកស៊ុតការសិក្សា 27
- ជំងឺលីម្វូស៊ីតប្រចាំការសិក្សា 27
- បេះដូងខ្សោយការសិក្សា 26
- មហារីកតំបក់ការសិក្សា 24
ពី ClinicalTrials.gov, ទិន្នន័យទទួលបាននៅថ្ងៃ 6 តុលា 2026។ ការសិក្នានីមួយៗកំណត់លក្ខខណ្ឌលក្ខណៈសម្បត្តិរបស់ខ្លួន; ក្រុមការងារសិក្សាកំណត់ថាតើនរណាអាចចូលរួម។